Damora Therapeutics (DMRA) Share-based Compensation Growth (1y) (2021 - 2026)
Damora Therapeutics (DMRA) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-69.95% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Damora Therapeutics |
731.26 Mn |
528.86 Mn |
- |
4,435.20% |
| Date | Value |
|---|
| Mar 31, 2026 |
4,435.20% |
| Dec 31, 2025 |
56.82% |
| Sep 30, 2025 |
-75.92% |
| Jun 30, 2025 |
-80.70% |
| Mar 31, 2025 |
-86.83% |
| Dec 31, 2024 |
-71.74% |
| Sep 30, 2024 |
-53.48% |
| Jun 30, 2024 |
-38.08% |
| Mar 31, 2024 |
-5.23% |
| Dec 31, 2023 |
-19.20% |
| Sep 30, 2023 |
4.72% |
| Jun 30, 2023 |
1.41% |
| Mar 31, 2023 |
2.14% |
| Dec 31, 2022 |
8.53% |
| Sep 30, 2022 |
14.68% |
| Jun 30, 2022 |
43.77% |
| Mar 31, 2022 |
36.18% |
| Dec 31, 2021 |
147.61% |
| Sep 30, 2021 |
809.70% |
| Jun 30, 2021 |
163.90% |
